Vitalograph

Vitalograph

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Vitalograph is a long-established, privately-held leader in respiratory diagnostic devices and clinical trial services. The company operates a dual business model, serving both healthcare providers with point-of-care diagnostic tools and the pharmaceutical industry with comprehensive endpoint solutions for respiratory-focused clinical trials. With a global footprint and deep expertise in respiratory physiology, Vitalograph is positioned at the intersection of clinical care and drug development for chronic respiratory diseases.

AsthmaCOPDCystic FibrosisInterstitial Lung DiseaseALSChronic Cough

Technology Platform

V-Core Measurement Technology for accurate spirometry and respiratory diagnostics, integrated with a clinical trial data management ecosystem for centralized, high-quality endpoint data collection and reporting.

Opportunities

Growth is driven by the rising global prevalence of chronic respiratory diseases and the pharmaceutical industry's increasing reliance on specialized partners for complex trial endpoints.
The shift towards decentralized and home-based clinical trials creates significant demand for Vitalograph's portable monitoring and data centralization solutions.

Risk Factors

Risks include dependence on the respiratory therapy market, potential technological disruption from digital health alternatives, and the ongoing regulatory and execution complexities of managing global clinical trial data services.
Any downturn in pharmaceutical R&D spending on respiratory drugs could impact the services segment.

Competitive Landscape

Vitalograph competes with large medical device companies (e.g., Vyaire, COSMED, ndd) in the diagnostic spirometry market and with large, full-service CROs (e.g., IQVIA, PPD) and specialty respiratory CROs in the clinical trial services space. Its deep, focused expertise in respiratory physiology and long-standing reputation are key differentiators.